|Bid||1.0100 x 1300|
|Ask||1.1700 x 1000|
|Day's Range||1.0400 - 1.1100|
|52 Week Range||0.8600 - 2.5000|
|Beta (5Y Monthly)||1.33|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jun 30, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 05, 2015|
|1y Target Est||4.00|
DUBLIN, Ireland, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Annual General Meeting (AGM). AGM Results On September 30, 2022 Trinity Biotech plc held an AGM of Shareholders at the Company’s headquarters at IDA Business Park, Bray, Co. Wicklow, Ireland. At the AGM, the Company’s shareholders approved the following resolutio
Trinity Biotech plc ( NASDAQ:TRIB ), might not be a large cap stock, but it received a lot of attention from a...
Does the July share price for Trinity Biotech plc ( NASDAQ:TRIB ) reflect what it's really worth? Today, we will...